Siegel Jay P, O'Neill Robert T, Temple Robert, Campbell Gregory, Foulkes Mary A
Center for Biologics Evaluations and Research, Food and Drug Administration, Rockville, MD 20852, USA.
Stat Med. 2004 May 30;23(10):1527-9. doi: 10.1002/sim.1789.
This discussion considers arguments for and against separating responsibility for the unblinded interim analysis of a clinical trial from responsibility for trial management and modifications to the ongoing trial. The degree to which one or different statisticians carry out these responsibilities and thus the degree of statistician independence for the two activities can vary, but a sponsor should recognize that giving a single statistician both responsibilities might limit flexibility in managing the trial, particularly with respect to modifying an ongoing trial.
本讨论考虑了支持和反对将临床试验非盲期中分析的责任与试验管理及对正在进行的试验进行修改的责任分开的论据。一名或不同的统计学家履行这些职责的程度,以及因此这两项活动中统计学家的独立程度可能会有所不同,但申办者应认识到,让一名统计学家承担这两项责任可能会限制试验管理的灵活性,特别是在修改正在进行的试验方面。